Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation in leukemia

P A Rowlings1, R P Gale, M M Horowitz

  • 1International Bone Marrow Transplant Registry, Milwaukee, WI.

Journal of Hematotherapy
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parent versus child donor perceptions of the bone marrow donation experience.

Bone marrow transplantation·2017
Same author

Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis.

Bone marrow transplantation·2016
Same author

Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft.

Bone marrow transplantation·2016
Same author

Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN.

Bone marrow transplantation·2016
Same author

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.

Bone marrow transplantation·2014
Same author

Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts.

Bone marrow transplantation·2014
Same journal

Comparative evaluation of procedures with a Baxter CS-3000 cell separator for collecting peripheral blood cells from children.

Journal of hematotherapy·1999
Same journal

Graft engineering of G-CSF-mobilized allogeneic leukapheresis products by counterflow centrifugal elutriation after CD34 column adsorption.

Journal of hematotherapy·1999
Same journal

Serum granulocyte colony-stimulating factor kinetics in children receiving intense chemotherapy with or without stem cell support.

Journal of hematotherapy·1999
Same journal

Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92.

Journal of hematotherapy·1999
Same journal

The differentiating effect of retinoic acid and vincristine on acute myeloid leukemia.

Journal of hematotherapy·1999
Same journal

Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapse.

Journal of hematotherapy·1999
See all related articles

Bone marrow transplants are a growing treatment for leukemia. Studies identify key factors for successful allogeneic transplants and explore autologous transplants as an alternative therapy, improving long-term survival.

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Bone marrow transplantation is a critical therapeutic modality for leukemia.
  • Advances in transplantation have expanded treatment options beyond HLA-identical siblings.

Purpose of the Study:

  • To review variables predicting outcomes in allogeneic bone marrow transplants for leukemia.
  • To discuss the role of graft-versus-leukemia (GVL) effects.
  • To evaluate the increasing use and investigation of autologous transplants.

Main Methods:

  • Analysis of data from International Bone Marrow Transplant Registry (IBMTR) studies.
  • Identification of prognostic variables for transplant outcomes.
  • Review of literature on graft-versus-leukemia (GVL) and autologous transplant efficacy.

Related Experiment Videos

Main Results:

  • Several IBMTR studies have identified key variables predicting outcomes in allogeneic transplants.
  • Graft-versus-leukemia (GVL) factors enhance the understanding of leukemia treatment efficacy.
  • Allografts from related and unrelated donors, alongside autologous transplants, are increasingly successful and achieving long-term leukemia-free survival (LFS).

Conclusions:

  • Bone marrow transplantation, including allogeneic and autologous approaches, is a vital and evolving treatment for leukemia.
  • Continued research into transplant variables and alternative therapies like autologous transplants is crucial for improving patient outcomes and long-term leukemia-free survival.